BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 28, 2009
View Archived Issues
GeoVax requests pre-IND meeting with FDA for therapeutic AIDS vaccine
Read More
Chugai is granted additional approvals in China for Xeloda and Avastin
Read More
EMEA accepts for review Pharming's MAA for Rhucin for hereditary angioedema
Read More
2009 influenza A (H1N1) vaccine generates immune response in children
Read More
Alimera Sciences starts pilot study of Iluvien in patients with macular edema
Read More
Alizyme provides update on sale of Cetilistat
Read More
BioSante and Cell Genesys confirm final exchange ratio for merger
Read More
Nifurtimox/eflornithine combination therapy for sleeping sickness now available
Read More
Pluristem Therapeutics doses first patient in phase I trial for PAD
Read More
Protalix Biotherapeutics presents preclinical data on pr-anti-TNF for arthritis
Read More
Sangamo BioSciences plans to initiate second CCR5-ZFP trial in HIV/AIDS
Read More
TGen commences clinical trials for OSI-906 for adrenocortical carcinoma
Read More
Icagen initiates proof-of-concept study of ICA-105665 in photosensitive epilepsy
Read More
E.C. grants Gilead Sciences conditional marketing approval for Cayston
Read More
ASP-2151 inhibits VZV and HSV-1/-2 activity in vitro and reduces HSV-1 pathology in vivo
Read More
Shionogi and GSK report data from phase II trials of HIV integrase inhibitor S/GSK-1349572
Read More
ZT-031 shows favorable PK as intranasal formulation in preclinical evaluation
Read More
4SC-201 shows favorable oral profile and tolerability in patients with solid tumors
Read More
BIIB-022 shown to be safe in phase I trial in relapsed/refractory solid tumor patients
Read More
NicOx discovers NO donors for the treatment of hypertension and other conditions
Read More
HDAC inhibitors for the treatment of cancer presented by Roche
Read More
Boehringer Ingelheim claims BK1 receptor antagonists as analgesics
Read More
Cycloindole derivatives for the treatment of HCV infection described by iTherX
Read More
Cephalon discloses histamine H3 antagonists for the treatment of sleep disorders
Read More
NicOx submits NDA to FDA for naproxcinod in osteoarthritis
Read More
FDA grants accelerated approval to Allos Therapeutics' Folotyn for relapsed or refractory PTCL
Read More